18 Aug - Pfizer's investment case
--:--
RMB's Matete Thulare unpacks BHP's excellent results. Keith McLachlan, Integral Asset Management, on why Pfizer is his preferred global healthcare stock. Anchor's Henry Biddlecombe asks whether Apple can double in value from here.